Benlazar S M A
@smbenlazar
Professor of hematology, Universitary hospital of Sidi Bel Abbés. Head, Hospitalisation and Geriatric Unit.
Giant Proerythroblast showing dog ear-like cytoplasmic pseudopodia (due to Parvovirus B19) with Pure red cell aplasia, Bone marrow aspiration imagebank.hematology.org/image/65531/gi…

Zanubrutinib and Venetoclax for Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With and Without Del(17p)/TP53 Mutation: SEQUOIA Arm D Results ascopubs.org/doi/10.1200/JC… #leusm

With a high rate of ≥grade 3 toxicities, Is BrECADD better than Nivo AVD in elderly patients with advanced Hodgkin lymphoma? >>>PET–Guided BrECADD in Older Patients With Advanced-Stage Classic HL ascopubs.org/doi/10.1200/JC…
Aggressive NK Cell Leukemia: Marrow Aspirate | ASH Image Bank | American Society of Hematology imagebank.hematology.org/image/3188/agg… #ASHImageBank

hepatosplenic T cell lymphoma | ASH Image Bank | American Society of Hematology imagebank.hematology.org/image/61461/he… #ASHImageBank

Relapsed/refractory multiple myeloma: standard of care management of patients in the Gulf region | Published in Clinical Hematology International, the official peer-reviewed journal of @TheIACH chi.scholasticahq.com/article/137860…
Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells mdpi.com/3388724 #mdpicancers via @Cancers_MDPI #lymsm

Chronic Lymphocytic Leukemia: Novel Therapeutic Targets Under Investigation mdpi.com/3397314 #mdpicancers via @Cancers_MDPI #leusm

Molecular Pathways and Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) mdpi.com/3399688 #mdpicancers via @Cancers_MDPI #lymsm

Hi friends, it's #AcuteMyeloidLeukemia Thursday. Here are Top Posts of the Week! 🎉🎉🎉 1/ Our friend @smbenlazar with a 2025 update from @AjHematology: x.com/smbenlazar/sta…
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management onlinelibrary.wiley.com/doi/10.1002/aj… #AML #leusm
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and Management onlinelibrary.wiley.com/doi/10.1002/aj… #AML #leusm

A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia frontiersin.org/journals/immun… #AML #leusm

Good for a prolonged survival #CLL #leusm -Smudge cells - 1. | ASH Image Bank | American Society of Hematology imagebank.hematology.org/image/1023/smu… #ASHImageBank

Plasma Cell Crystalline Inclusions in ALK‐Negative Anaplastic Large Cell Lymphoma - Kinoshita - 2025 - eJHaem - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/jh…

Proposed therapeutic algorithm for mantle cell lymphoma including both clinically available and experimental drugs, expected in the near future mdpi.com/2072-6694/17/1… #lymsm

Next-Generation Therapies in Mantle Cell Lymphoma (MCL): The Evolving Landscape in Treatment of Relapse/Refractory After CAR-T Cells mdpi.com/3388724 #mdpicancers via @Cancers_MDPI

Chronic lymphocytic leukaemia extravaganza: Vacuolated lymphoma cells onlinelibrary.wiley.com/doi/10.1111/bj…

Treatment algorithm for frontline Ph-positive B-cell ALL (2025 Update) onlinelibrary.wiley.com/doi/10.1002/aj… @DrHKantarjian @MDAndersonNews #leusm
